Overview
CCDS builds AI/ML healthcare solutions by combining Mass General Brigham clinicians with strong computing resources, supporting the full lifecycle from concept to care integration. Their approach blends clinical insight with advanced computing to develop models, validate them in real-world settings, and embed them into care workflows within the health system. They differ from others by having direct access to a large real-world clinical dataset and a network of clinicians across Mass General Brigham for end-to-end development and seamless care integration. The goal is to deliver AI tools that meaningfully support clinicians and improve patient outcomes by tightly integrating into hospital workflows.
Work here?Claim your company
Simplify's take
What believers are saying
- On October 19, 2026, CCDS signed CAD $88.9 million in potential five-year billings.
- Initial deployment begins November 1, 2026, with a paid deposit already secured.
- Beacon Securities raised its target to $3.75 after the Alpharetta contract.
What critics are saying
- CCDS still relies on one customer for Alpharetta's first four megawatts.
- Revenue depends on Georgia Power approval for expansion beyond 11.7 MW.
- A failed November 1, 2026 deployment would kill the contract's credibility and pipeline.
What makes CCDS unique
- CCDS controls 11.7 MW after Alpharetta, pairing leased capacity with long-term colocation contracts.
- Its 2026 roll-up model targets Tier II/III assets, not greenfield hyperscale builds.
- The Alpharetta lease spans 15.5 years, anchoring recurring cash flow visibility.
Help us improve and share your feedback! Did you find this helpful?